Literature DB >> 17355413

Detection of Celiac disease in primary care: a multicenter case-finding study in North America.

Carlo Catassi1, Deborah Kryszak, Otto Louis-Jacques, Donald R Duerksen, Ivor Hill, Sheila E Crowe, Andrew R Brown, Nicholas J Procaccini, Brigid A Wonderly, Paul Hartley, James Moreci, Nathan Bennett, Karoly Horvath, Margaret Burk, Alessio Fasano.   

Abstract

BACKGROUND: Celiac disease (CD) is one of the most common lifelong disorders in western countries. However, most cases remain currently undiagnosed in North America, mostly due to poor awareness of CD by primary care physicians.
OBJECTIVES: The aims of this study were (a) to determine whether an active case-finding strategy in primary care could increase the frequency of CD diagnosis and (b) to determine the most common clinical presentations of the condition.
METHODS: This was a multicenter, prospective study involving adult subjects during the years 2002-2004, attending one of the participating practices. All individuals with symptoms or conditions known to be associated with CD were tested for immunoglobulin A anti-transglutaminase (tTG) antibodies, and those with elevated anti-tTG were subsequently tested for IgA antiendomysial antibodies (EMA). All subjects who were positive for EMA were advised to undergo an intestinal biopsy and HLA typing.
RESULTS: The study group included 737 women and 239 men, with a median age of 54.3 yr. A positive anti-tTG test was found in 30 out of 976 investigated subjects (3.07%, 95% CI 1.98-4.16). CD was diagnosed in 22 patients (18 women, 4 men). The most frequent reasons for CD screening in these 22 cases were bloating (12/22), thyroid disease (11/22), irritable bowel syndrome (7/22), unexplained chronic diarrhea (6/22), chronic fatigue (5/22), and constipation (4/22). The prevalence of CD in the serologically screened sample was 2.25% (95% CI 1.32-3.18). The diagnostic rate was low at baseline (0.27 cases per thousand visits, 95% CI 0.13-0.41) and significantly increased to 11.6 per thousand visits (95% CI 6.8-16.4, P < 0.001) following active screening implementation.
CONCLUSIONS: This study demonstrates that an active case-finding strategy in the primary care setting is an effective means to improve the diagnostic rate of CD in North America.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17355413     DOI: 10.1111/j.1572-0241.2007.01173.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  71 in total

1.  Increased prevalence of transglutaminase 6 antibodies in sera from schizophrenia patients.

Authors:  Nicola G Cascella; Debby Santora; Patricia Gregory; Deanna L Kelly; Alessio Fasano; William W Eaton
Journal:  Schizophr Bull       Date:  2012-04-19       Impact factor: 9.306

2.  Case 1: Going forward in lack of movement.

Authors:  Mohsin Rashid
Journal:  Paediatr Child Health       Date:  2011-04       Impact factor: 2.253

3.  Procedure volume influences adherence to celiac disease guidelines.

Authors:  Benjamin Lebwohl; Robert M Genta; Robert C Kapel; Daniel Sheehan; Nina S Lerner; Peter H Green; Alfred I Neugut; Andrew Rundle
Journal:  Eur J Gastroenterol Hepatol       Date:  2013-11       Impact factor: 2.566

4.  Screening for celiac disease in average-risk and high-risk populations.

Authors:  Saurabh Aggarwal; Benjamin Lebwohl; Peter H R Green
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

Review 5.  Nonceliac Gluten Sensitivity.

Authors:  Anna Krigel; Benjamin Lebwohl
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

6.  Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up.

Authors:  Umberto Volta; Alessandro Granito; Erica Fiorini; Claudia Parisi; Maria Piscaglia; Georgios Pappas; Paolo Muratori; Francesco B Bianchi
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

Review 7.  Pearls and pitfalls in the diagnosis of adult celiac disease.

Authors:  H J Freeman
Journal:  Can J Gastroenterol       Date:  2008-03       Impact factor: 3.522

Review 8.  Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis.

Authors:  Andrew J Irvine; William D Chey; Alexander C Ford
Journal:  Am J Gastroenterol       Date:  2016-10-18       Impact factor: 10.864

9.  Performance of serology assays for diagnosing celiac disease in a clinical setting.

Authors:  Miriam Parizade; Yoram Bujanover; Batya Weiss; Vered Nachmias; Bracha Shainberg
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

10.  Celiac disease in patients with presumed irritable bowel syndrome: a case-finding study.

Authors:  Khaled Ali Jadallah; Yousef Saleh Khader
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.